(Q34027488)

30 July 2017

1 reference

title

Natriuretic peptides in the pathophysiology of congestive heart failure (English)

1 reference

30 July 2017

0 references

1 reference

congestive heart failure

1 reference

Chen HH

1

1 reference

30 July 2017

Burnett JC

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 May 2000

1 reference

Current cardiology reports

30 July 2017

1 reference

30 July 2017

2

1 reference

30 July 2017

3

1 reference

30 July 2017

198-205

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-000-0069-3

30 July 2017

0 references

cites work

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Molecular biology of the natriuretic peptides and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Angiotensin II in the evolution of experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Circulating beta-atrial natriuretic factor in congestive heart failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-000-0069-3

Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload

21 January 2018

1 reference

12 December 2020

Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma

1 reference

12 December 2020

Insertion/deletion polymorphism within a polyadenylate stretch at the human atrial natriuretic peptides (hANP) gene locus

1 reference

12 December 2020

Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders

1 reference

12 December 2020

Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failure

1 reference

12 December 2020

Endothelin-stimulated secretion of natriuretic peptides by rat atrial myocytes is mediated by endothelin A receptors.

1 reference

12 December 2020

Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects

1 reference

12 December 2020

Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure

1 reference

12 December 2020

Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

1 reference

12 December 2020

Biochemical detection of left-ventricular systolic dysfunction.

1 reference

12 December 2020

Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide

1 reference

12 December 2020

Effects of synthetic atrial natriuretic factor on renal function and renin release

1 reference

12 December 2020

Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure.

1 reference

12 December 2020

Renal actions of synthetic dendroaspis natriuretic peptide.

1 reference

12 December 2020

A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)

1 reference

12 December 2020

Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II.

1 reference

12 December 2020

Physiological role of silent receptors of atrial natriuretic factor

1 reference

12 December 2020

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

12 December 2020

Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly.

1 reference

12 December 2020

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension

1 reference

12 December 2020

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

1 reference

12 December 2020

Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A

1 reference

12 December 2020

Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

1 reference

12 December 2020

C-type natriuretic peptide inhibits intimal thickening after vascular injury

1 reference

12 December 2020

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

1 reference

12 December 2020

Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure

1 reference

12 December 2020

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

12 December 2020

A dicarba analog of beta-atrial natriuretic peptide (beta-ANP) inhibits guanosine 3',5'-cyclic monophosphate production induced by alpha-ANP in cultured rat vascular smooth muscle cells

1 reference

12 December 2020

Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure

1 reference

12 December 2020

Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments

1 reference

12 December 2020

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

1 reference

12 December 2020

Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor

1 reference

12 December 2020

Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure

1 reference

12 December 2020

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

1 reference

12 December 2020

Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.

1 reference

12 December 2020

Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure

1 reference

12 December 2020

Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation

1 reference

12 December 2020

Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure

1 reference

12 December 2020

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

1 reference

12 December 2020

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

12 December 2020

ANF-mediated renal cGMP generation in congestive heart failure

1 reference

12 December 2020

Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

1 reference

12 December 2020

Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction

1 reference

12 December 2020

Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma

1 reference

12 December 2020

Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure

1 reference

12 December 2020

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

12 December 2020

10.1007/S11886-000-0069-3

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference